Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.
(00:31)
Could you please provide a little bit about yourself and your background?
(01:30)
Would you please share a brief overview of the UBA1Q assay?
(02:13)
Would you provide an overview of VEXAS syndrome?
(05:30)
When is this testing recommended during care for patients who have a suspected inflammatory condition or VEXAS syndrome?
(06:38)
What advantage does this assay provide over other methodologies?
(10:13)
Could you share further why diagnosis is so important for these patients?
(12:40)
Is there anything else you'd like to comment about the assay?